Hepatic dysfunction in recipients of renal allografts.
D000410:Alanine Transaminase / Q000097:blood; D000469:Alkaline Phosphatase / Q000097:blood; D000956:Antigens, Viral / Q000032:analysis; D001219:Aspartate Aminotransferases / Q000097:blood; D001379:Azathioprine / Q000009:adverse effects* / Q000627:therapeutic use; D001663:Bilirubin / Q000097:blood; D001707:Biopsy, Needle; D056486:Chemical and Drug Induced Liver Injury; D003520:Cyclophosphamide / Q000494:pharmacology / Q000627:therapeutic use; D003587:Cytomegalovirus / Q000302:isolation & purification; D006515:Hepatitis B virus; D006801:Humans; D016030:Kidney Transplantation; D008099:Liver / Q000378:metabolism / Q000473:pathology; D008107:Liver Diseases / Q000209:etiology*; D008775:Methylprednisolone / Q000627:therapeutic use; D011241:Prednisone / Q000627:therapeutic use; D014184:Transplantation, Homologous
D000956:Antigens, Viral; D003520:Cyclophosphamide; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D000469:Alkaline Phosphatase; D001379:Azathioprine; D001663:Bilirubin; D011241:Prednisone; D008775:Methylprednisolone